Katelyn G. Bennett, MD and Christian J. Vercler, MD, MA
Plastic surgeons who use patient images for online advertising should ensure informed consent and not exploit the patient-physician relationship for gain.
AMA J Ethics. 2018;20(4):328-335. doi:
10.1001/journalofethics.2018.20.4.ecas1-1804.
Monitoring surgeons’ capacities over time are rooted in professional duties to protect patients’ safety. Aging surgeons should undergo assessments and be encouraged to stop practicing before their diminished skill becomes too risky.
AMA J Ethics. 2016;18(10):986-992. doi:
10.1001/journalofethics.2016.18.10.ecas2-1610.
Plastic surgeons’ use of patient images on social media should conform to the American Society of Plastic Surgeons’ advertising and image use guidelines.
AMA J Ethics. 2018;20(4):379-383. doi:
10.1001/journalofethics.2018.20.4.msoc3-1804.
Devan Stahl, PhD, MDiv and Christian J. Vercler, MD, MA
Social and cultural influences significantly contribute to our conceptions of healthy and pathological anatomy, and surgeons play critical roles in how these influences are expressed in clinical settings and social media.
AMA J Ethics. 2018;20(4):384-391. doi:
10.1001/journalofethics.2018.20.4.msoc4-1804.
Joel A. DeLisa, MD, MS and Jacob Jay Lindenthal, PhD, DrPH
Research on experiences of practicing physicians who have disabilities could help medical schools counsel applicants and increase enrollment among students with disabilities. This can ultimately improve care for patients with disabilities.
AMA J Ethics. 2016;18(10):1003-1009. doi:
10.1001/journalofethics.2016.18.10.stas1-1610.
The law and medical ethics demand reconsideration of inflexible technical standards that are vulnerable to litigation under disability discrimination laws.
AMA J Ethics. 2016;18(10):1010-1016. doi:
10.1001/journalofethics.2016.18.10.hlaw1-1610.
Charles E. Binkley, MD, Michael S. Politz, MA, and Brian P. Green, PhD
If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.
AMA J Ethics. 2021;23(9):E745-749. doi:
10.1001/amajethics.2021.745.